Cargando…
Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication
Objectives: We theorized that myelodysplastic syndrome (MDS) with somatic mutations and karyotype abnormalities are associated with autoinflammation, and that the presence of autoinflammatory disease affected prognosis in MDS. Methods: One hundred thirty-four MDS patients were assessed for the preva...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933213/ https://www.ncbi.nlm.nih.gov/pubmed/33679746 http://dx.doi.org/10.3389/fimmu.2021.610019 |
_version_ | 1783660561301504000 |
---|---|
author | Watad, Abdulla Kacar, Mark Bragazzi, Nicola Luigi Zhou, Qiao Jassam, Miriam Taylor, Jan Roman, Eve Smith, Alexandra Jones, Richard A. Amital, Howard Cargo, Catherine McGonagle, Dennis Savic, Sinisa |
author_facet | Watad, Abdulla Kacar, Mark Bragazzi, Nicola Luigi Zhou, Qiao Jassam, Miriam Taylor, Jan Roman, Eve Smith, Alexandra Jones, Richard A. Amital, Howard Cargo, Catherine McGonagle, Dennis Savic, Sinisa |
author_sort | Watad, Abdulla |
collection | PubMed |
description | Objectives: We theorized that myelodysplastic syndrome (MDS) with somatic mutations and karyotype abnormalities are associated with autoinflammation, and that the presence of autoinflammatory disease affected prognosis in MDS. Methods: One hundred thirty-four MDS patients were assessed for the prevalence of autoinflammatory complications and its link with karyotypes and somatic mutation status. Autoinflammatory complications were described either as well-defined autoinflammatory diseases (AD) or undifferentiated “autoinflammatory disease” (UAD) (defined as CRP over 10.0 mg/L on five consecutive occasions, taken at separate times and not explained by infection). Several patient characteristics including demographic, clinical, laboratory, cytogenetics charts, and outcomes, were compared between different groups. Results: Sixty-two (46.3%) patients had an autoinflammatory complication manifesting as arthralgia (43.5% vs. 23.6%, p = 0.0146), arthritis (30.6% vs. 15.3%, p = 0.0340), skin rash (27.4% vs. 12.5%, p = 0.0301), pleuritis (14.5% vs. 4.2%, p = 0.0371) and unexplained fever (27.4% vs. 0%, p < 0.0001). AD were found in 7.4% of MDS patients (with polymyalgia rheumatic being the most frequently one). Classical autoimmune diseases were found only in 4 MDS patients (3.0%). Transcription factor pathway mutations (RUNX1, BCOR, WTI, TP53) (OR 2.20 [95%CI 1.02–4.75], p = 0.0451) and abnormal karyotypes (OR 2.76 [95%CI 1.22–6.26], p = 0.0153) were associated with autoinflammatory complications. Acute leukaemic transformation was more frequent in MDS patients with autoinflammatory features than those without (27.4% vs. 9.7%, p = 0.0080). Conclusions: Autoinflammatory complications are common in MDS. Somatic mutations of transcription factor pathways and abnormal karyotypes are associated with greater risk of autoinflammatory complications, which are themselves linked to malignant transformation and a worse prognosis. |
format | Online Article Text |
id | pubmed-7933213 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79332132021-03-06 Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication Watad, Abdulla Kacar, Mark Bragazzi, Nicola Luigi Zhou, Qiao Jassam, Miriam Taylor, Jan Roman, Eve Smith, Alexandra Jones, Richard A. Amital, Howard Cargo, Catherine McGonagle, Dennis Savic, Sinisa Front Immunol Immunology Objectives: We theorized that myelodysplastic syndrome (MDS) with somatic mutations and karyotype abnormalities are associated with autoinflammation, and that the presence of autoinflammatory disease affected prognosis in MDS. Methods: One hundred thirty-four MDS patients were assessed for the prevalence of autoinflammatory complications and its link with karyotypes and somatic mutation status. Autoinflammatory complications were described either as well-defined autoinflammatory diseases (AD) or undifferentiated “autoinflammatory disease” (UAD) (defined as CRP over 10.0 mg/L on five consecutive occasions, taken at separate times and not explained by infection). Several patient characteristics including demographic, clinical, laboratory, cytogenetics charts, and outcomes, were compared between different groups. Results: Sixty-two (46.3%) patients had an autoinflammatory complication manifesting as arthralgia (43.5% vs. 23.6%, p = 0.0146), arthritis (30.6% vs. 15.3%, p = 0.0340), skin rash (27.4% vs. 12.5%, p = 0.0301), pleuritis (14.5% vs. 4.2%, p = 0.0371) and unexplained fever (27.4% vs. 0%, p < 0.0001). AD were found in 7.4% of MDS patients (with polymyalgia rheumatic being the most frequently one). Classical autoimmune diseases were found only in 4 MDS patients (3.0%). Transcription factor pathway mutations (RUNX1, BCOR, WTI, TP53) (OR 2.20 [95%CI 1.02–4.75], p = 0.0451) and abnormal karyotypes (OR 2.76 [95%CI 1.22–6.26], p = 0.0153) were associated with autoinflammatory complications. Acute leukaemic transformation was more frequent in MDS patients with autoinflammatory features than those without (27.4% vs. 9.7%, p = 0.0080). Conclusions: Autoinflammatory complications are common in MDS. Somatic mutations of transcription factor pathways and abnormal karyotypes are associated with greater risk of autoinflammatory complications, which are themselves linked to malignant transformation and a worse prognosis. Frontiers Media S.A. 2021-02-19 /pmc/articles/PMC7933213/ /pubmed/33679746 http://dx.doi.org/10.3389/fimmu.2021.610019 Text en Copyright © 2021 Watad, Kacar, Bragazzi, Zhou, Jassam, Taylor, Roman, Smith, Jones, Amital, Cargo, McGonagle and Savic. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Watad, Abdulla Kacar, Mark Bragazzi, Nicola Luigi Zhou, Qiao Jassam, Miriam Taylor, Jan Roman, Eve Smith, Alexandra Jones, Richard A. Amital, Howard Cargo, Catherine McGonagle, Dennis Savic, Sinisa Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication |
title | Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication |
title_full | Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication |
title_fullStr | Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication |
title_full_unstemmed | Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication |
title_short | Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication |
title_sort | somatic mutations and the risk of undifferentiated autoinflammatory disease in mds: an under-recognized but prognostically important complication |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933213/ https://www.ncbi.nlm.nih.gov/pubmed/33679746 http://dx.doi.org/10.3389/fimmu.2021.610019 |
work_keys_str_mv | AT watadabdulla somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication AT kacarmark somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication AT bragazzinicolaluigi somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication AT zhouqiao somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication AT jassammiriam somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication AT taylorjan somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication AT romaneve somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication AT smithalexandra somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication AT jonesricharda somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication AT amitalhoward somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication AT cargocatherine somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication AT mcgonagledennis somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication AT savicsinisa somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication |